CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-29 | Thompson Peter A. Director | Purchase | +500,000 | $6.20 | $3.1M | 8,019,187 |
| 2023-08-04 | Shawver Laura Director | Exercise or conversion 10b5-1 | +18,897 | $1.27 | $24K | 229,243 |
| 2023-08-04 | Shawver Laura Director | Sale 10b5-1 | −18,897 | $7.06 | $133K | 210,346 |
| 2023-08-04 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −18,897 | 2,997 | ||
| 2023-08-03 | Shawver Laura Director | Exercise or conversion 10b5-1 | +26,107 | $1.27 | $33K | 236,453 |
| 2023-08-03 | Shawver Laura Director | Sale 10b5-1 | −26,107 | $7.01 | $183K | 210,346 |
| 2023-08-03 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −26,017 | 21,894 | ||
| 2023-08-02 | Shawver Laura Director | Exercise or conversion 10b5-1 | +36,281 | $1.27 | $46K | 246,627 |
| 2023-08-02 | Shawver Laura Director | Sale 10b5-1 | −36,281 | $7.09 | $257K | 210,346 |
| 2023-08-02 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −36,281 | 48,001 | ||
| 2023-08-01 | Shawver Laura Director | Exercise or conversion 10b5-1 | +18,715 | $1.27 | $24K | 229,061 |
| 2023-08-01 | Shawver Laura Director | Sale 10b5-1 | −18,715 | $7.19 | $135K | 210,346 |
| 2023-08-01 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −18,715 | 84,282 | ||
| 2023-07-07 | Shawver Laura Director | Exercise or conversion | +8,858 | $1.27 | $11K | 219,204 |
| 2023-07-07 | Shawver Laura Director | Sale | −8,858 | $6.36 | $56K | 210,346 |
| 2023-07-07 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) | −8,858 | 102,997 | ||
| 2023-07-06 | Shawver Laura Director | Exercise or conversion | +33,510 | $1.27 | $43K | 243,856 |
| 2023-07-06 | Shawver Laura Director | Sale | −33,510 | $6.34 | $213K | 210,346 |
| 2023-07-06 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) | −33,510 | 111,855 | ||
| 2023-07-05 | Shawver Laura Director | Exercise or conversion | +31,112 | $1.27 | $40K | 241,458 |
Page 21 of 31 · 602 trades